Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hsp90 inhibitors as senolytic drugs to extend healthy aging

3 May 2018

Abstract excerpt

Aging is characterized by progressive decay of biological systems and although it is not considered a disease, it is one of the main risk factors for chronic diseases and many types of cancers. The accumulation of senescent cells in various tissues is thought to be a major factor contributing to aging and age-related diseases. Removal of senescent cells during aging by either genetic or therapeutic methods have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetics, Aging, and Longevity in Model Organisms
Share to Heat shock proteins research
Share to Telomeres, Telomerase, and Senescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29886783
DOI: 10.1080/15384101.2018.1475828

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hsp90 inhibitors as senolytic drugs to extend healthy agingPMID 29886783Read ↗

Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.Semantic proximity Read ↗

Targeting cellular senescence with senotherapeutics: senolytics and senomorphicsSemantic proximity Read ↗

Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging InterventionsSemantic proximity Read ↗

Identification of HSP90 inhibitors as a novel class of senolyticsSemantic proximity Read ↗

A second generation of senotherapies: the development of targeted senolytics, senoblockers and senoreversers for healthy ageingSemantic proximity Read ↗

Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.Semantic proximity Read ↗

Cellular senescence: a key therapeutic target in aging and diseasesSemantic proximity Read ↗

Discovery, development, and future application of senolytics: theories and predictions.Semantic proximity Read ↗

Current senolytics: Mode of action, efficacy and limitations, and their future.Semantic proximity Read ↗

Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing StrategiesSemantic proximity Read ↗

Comparative Analysis of drugs that improve the Quality of Life and Life ExpectancySemantic proximity Read ↗

Recent Advances in Senolysis for Age-Related DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.